PTC
ANIP icon

Petrus Trust Company’s ANI Pharmaceuticals ANIP Stock Holding History

Petrus Trust Company’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,652
Closed -$499K – 190
2025
Q2 		$499K Buy
+7,652
New +$498K 0.05% 116
2024
Q4 		– Sell
-4,342
Closed -$259K – 586
2024
Q3 		$259K Buy
4,342
+713
+20% +$43.5K 0.03% 460
2024
Q2 		$231K Hold
3,629
– – 0.02% 514
2024
Q1 		$251K Hold
3,629
– – 0.02% 501
2023
Q4 		$200K Sell
3,629
-2,122
-37% -$117K 0.02% 563
2023
Q3 		$334K Hold
5,751
– – 0.04% 350
2023
Q2 		$310K Buy
+5,751
New +$255K 0.03% 350

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Petrus Trust Company's ANIP Position: Q3 2025 in Review

Petrus Trust Company sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 7,652 shares — an estimated $499K sold.

Petrus Trust Company first reported a position in ANIP in Q2 2023 and held it in 7 quarters. The position peaked at $499K in Q2 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • Petrus Trust Company reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Petrus Trust Company sold 7,652 ANI Pharmaceuticals shares in Q3 2025, an estimated $499K.
  • Petrus Trust Company first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Petrus Trust Company's ANI Pharmaceuticals position peaked at $499K in Q2 2025.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.